Vaginal Estrogen With Pessary Treatment

• Status: Completed
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

Patients presenting with pelvic organ prolapse will be offered the use of a pessary. Vaginal estrogen cream treatment with the pessary will be randomized amongst the patients and patient satisfaction and complication rates will be assessed during follow-up.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Lawson Health Research Institute
• Collaborators: Academic Medical Organization of Southwestern Ontario; University of Western Ontario, Canada
• Treatments: Estrogens; Estrogens, Conjugated (USP)

Criteria

Inclusion Criteria:

• Any patient presenting to the clinic with pelvic organ prolapse will be offered management with a pessary and will be offered participation in the study.

Exclusion Criteria:

• have a contraindication to the use of estrogen cream or products

• have any allergy to the use of estrogen cream or products

• have a past medical or family history of breast cancer

• have a past medical history of thromboembolism, myocardial infarction and stroke or are pregnant

• have previously used Premarin vaginal cream

• are currently using oral estrogen

• are not competent to consent